Financhill
Sell
47

MSFT Quote, Financials, Valuation and Earnings

Last price:
$487.99
Seasonality move :
7.81%
Day range:
$484.83 - $489.16
52-week range:
$344.79 - $555.45
Dividend yield:
0.7%
P/E ratio:
34.72x
P/S ratio:
12.40x
P/B ratio:
9.99x
Volume:
5.9M
Avg. volume:
25.5M
1-year change:
11.08%
Market cap:
$3.6T
Revenue:
$281.7B
EPS (TTM):
$14.06

Earnings Data

Next earnings date for MSFT
Jan 28
2026
Most recent earnings per share
$3.72
Beat by $0.05
(Oct 29/2025)
Consensus Estimate
$3.66
(Oct 29/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

MSFT Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
01/28/2026 Q4 $80.3B -- -- $3.91 --
10/29/2025 Q3 $75.4B $77.7B $3.72 $3.66 $0.05
07/30/2025 Q2 $73.9B $76.4B $3.65 $3.38 $0.27
04/30/2025 Q1 $68.4B $70.1B $3.46 $3.22 $0.24
01/29/2025 Q4 $68.8B $69.6B $3.23 $3.12 $0.11
10/30/2024 Q3 $64.6B $65.6B $3.30 $3.11 $0.19
07/30/2024 Q2 $64.4B $64.7B $2.95 $2.94 $0.01
04/25/2024 Q1 $60.9B $61.9B $2.94 $2.84 $0.09
01/30/2024 Q4 $61.1B $62B $2.93 $2.77 $0.16
10/24/2023 Q3 -- $56.5B $2.99 -- --
07/25/2023 Q2 -- $56.2B $2.69 -- --
04/25/2023 Q1 -- $52.9B $2.45 -- --
01/24/2023 Q4 -- $52.7B $2.20 -- --
10/25/2022 Q3 -- $50.1B $2.35 -- --
07/26/2022 Q2 -- $51.9B $2.23 -- --
04/26/2022 Q1 -- $49.4B $2.22 -- --
01/25/2022 Q4 -- $51.7B $2.48 -- --
10/26/2021 Q3 -- $45.3B $2.71 -- --
07/27/2021 Q2 -- $46.2B $2.17 -- --
04/27/2021 Q1 -- $41.7B $2.03 -- --
01/26/2021 Q4 -- $43.1B $2.03 -- --
10/27/2020 Q3 -- $37.2B $1.82 -- --
07/22/2020 Q2 -- $38B $1.46 -- --
04/29/2020 Q1 -- $35B $1.40 -- --
01/29/2020 Q4 -- $36.9B $1.51 -- --
10/23/2019 Q3 -- $33.1B $1.38 -- --
07/18/2019 Q2 -- $33.6B $1.71 -- --
04/24/2019 Q1 -- $30.5B $1.14 -- --
01/30/2019 Q4 -- $32.4B $1.08 -- --
10/24/2018 Q3 -- $29B $1.14 -- --
07/19/2018 Q2 -- $30B $1.14 -- --
04/27/2018 Q1 -- $26.8B $0.95 -- --
01/31/2018 Q4 -- $28.9B -$0.82 -- --
10/26/2017 Q3 -- $24.4B $0.84 -- --
07/20/2017 Q2 -- $25.5B $1.03 -- --
04/27/2017 Q1 -- $23B $0.70 -- --
01/26/2017 Q4 -- $25.7B $0.80 -- --
10/20/2016 Q3 -- $21.9B $0.72 -- --
07/19/2016 Q2 -- $20.5B $0.39 -- --
04/21/2016 Q1 -- $20.4B $0.47 -- --
01/28/2016 Q4 -- $23.6B $0.62 -- --

Microsoft Corp. Earnings Questions

  • How Much did Microsoft Corp. Generate in Revenue Last Quarter?

    Microsoft Corp. reported $77.7B worth of top line sales in its most recent quarter.

  • Did Microsoft Corp. Beat Earnings Last Quarter?

    Microsoft Corp. announced earnings per share of $3.72 which represents a beat of analyst forecast a $3.66 per share.

  • Is Microsoft Corp. Profitable?

    Microsoft Corp. reported $53.6B that represents $7.18 per share over the last quarter.

  • What is the Analyst Consensus for Microsoft Corp. EPS Next Year?

    Microsoft Corp.'s earnings are forecast to grow from $13.64 per share to $13.42 per share next year representing an increase of 19.18%.

  • When is Microsoft Corp.'s Earnings Date?

    Microsoft Corp.'s next earnings date is January 28, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
85
HUT alert for Dec 25

Hut 8 Corp. [HUT] is up 0.65% over the past day.

Buy
80
TVTX alert for Dec 25

Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.

Buy
63
GPCR alert for Dec 25

Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock